C4 Therapeutics Inc. (CCCC)
NASDAQ: CCCC
· Real-Time Price · USD
2.60
-0.16 (-5.80%)
At close: Aug 20, 2025, 3:59 PM
2.59
-0.38%
Pre-market: Aug 21, 2025, 07:15 AM EDT
C4 Therapeutics Revenue
C4 Therapeutics reported an annual revenue of $35.58M, reflecting a 71.44% growth. For the quarter ending June 30, 2025, C4 Therapeutics generated $0 in revenue.
Revenue (ttm)
35.58M
Revenue Growth
71.44%
Price / Sales Ratio
7.02
Revenue / Employee
323.49K
Employees
110
Market Cap
185.04M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 35.58M | +71.44% |
| Dec 31, 2023 | 20.76M | -33.25% |
| Dec 31, 2022 | 31.1M | -32.08% |
| Dec 31, 2021 | 45.78M | +37.93% |
| Dec 31, 2020 | 33.2M | +55.25% |
| Dec 31, 2019 | 21.38M | +10.42% |
| Dec 31, 2018 | 19.36M | n/a |